Balance Sheet
Cash Flow Statement
AmortizationAmortizationAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

RedHill Biopharma (RDHL) Shares Issued (2017 - 2022)

RedHill Biopharma has reported Shares Issued over the past 6 years, most recently at $7.6 million for Q4 2022.

  • Quarterly Shares Issued fell 61.74% to $7.6 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $23.8 million through Dec 2022, down 69.69% year-over-year, with the annual reading at $7.8 million for FY2025, 6.04% down from the prior year.
  • Shares Issued was $7.6 million for Q4 2022 at RedHill Biopharma, down from $15.5 million in the prior quarter.
  • Over five years, Shares Issued peaked at $57.9 million in Q1 2021 and troughed at $273000.0 in Q2 2021.
  • The 4-year median for Shares Issued is $8.8 million (2020), against an average of $14.0 million.
  • The largest YoY upside for Shares Issued was 5580.59% in 2022 against a maximum downside of 98.77% in 2022.
  • A 4-year view of Shares Issued shows it stood at $18.4 million in 2018, then crashed by 54.53% to $8.4 million in 2020, then skyrocketed by 136.92% to $19.8 million in 2021, then plummeted by 61.74% to $7.6 million in 2022.
  • Per Business Quant, the three most recent readings for RDHL's Shares Issued are $7.6 million (Q4 2022), $15.5 million (Q2 2022), and $713000.0 (Q1 2022).